2 天
GlobalData on MSNPhoenix Molecular kicks off Phase II part of breast cancer combo trialThe Phase II portion is seeking to establish safety and efficacy of the company’s HER2 breast cancer therapy in combination ...
Researchers identify mitochondrial transfer between cancer and immune cells as a crucial mechanism for immune evasion. The ...
Yibin Kang, a professor in the Department of Molecular Biology, discussed new breast cancer research in his lab.
A multi-institutional study led by researchers at Children's Hospital of Philadelphia (CHOP) is the first to identify one of the allergens responsible for eosinophilic esophagitis (EoE), an ...
Doug Kellogg, professor of molecular, cell, and developmental biology at UC Santa Cruz, has been awarded $2.95 million from ...
Molecular diagnostics in oncology. There are several major avenues in cancer medicine, which utilize molecular-based assays ... of rare and diverse molecular events and therefore cannot be clinically ...
To capitalize on this significant moment, the team developed a system they called REVERT. REVERT initially identifies the genetic basis of cancer development and subsequently employs a molecular ...
Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...
This Genome Atlas also provides knowledge on the genetic basis of cancer progression and evolution and may help the biomedical research and healthcare system in India shift toward a vision of ...
The group of Prof. Charna Dibner contributes to translational chronobiology and chronomedicine by developing two major lines of research: ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果